197 related articles for article (PubMed ID: 1506276)
1. Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds.
Papadopoulou MV; Epperly MW; Shields DS; Bloomer WD
Jpn J Cancer Res; 1992 Apr; 83(4):410-4. PubMed ID: 1506276
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea's toxicity in vitro by two new bioreductive agents.
Papadopoulou MV; Mainwaring A; Bloomer WD
Jpn J Cancer Res; 1992 Aug; 83(8):907-13. PubMed ID: 1399828
[TBL] [Abstract][Full Text] [Related]
3. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD
Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530
[TBL] [Abstract][Full Text] [Related]
4. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
Papadopoulou MV; Bloomer WD
Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
[TBL] [Abstract][Full Text] [Related]
5. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
Denny WA; Roberts PB; Anderson RF; Brown JM; Phil D; Wilson WR
Int J Radiat Oncol Biol Phys; 1992; 22(3):553-6. PubMed ID: 1735695
[TBL] [Abstract][Full Text] [Related]
6. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as cytotoxin and radiosensitizer.
Papadopoulou MV; Ji M; Rao MK; Bloomer WD
Oncol Res; 1996; 8(10-11):425-34. PubMed ID: 9114435
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitization in multifraction schedules. II. Greater sensitization by 2-nitroimidazoles than by oxygen.
Taylor YC; Brown JM
Radiat Res; 1987 Oct; 112(1):134-45. PubMed ID: 3659294
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
[TBL] [Abstract][Full Text] [Related]
9. DNA-targeted 2-nitroimidazoles: studies of the influence of the phenanthridine-linked nitroimidazoles, 2-NLP-3 and 2-NLP-4, on DNA damage induced by ionizing radiation.
Buchko GW; Weinfeld M
Radiat Res; 2002 Sep; 158(3):302-10. PubMed ID: 12175307
[TBL] [Abstract][Full Text] [Related]
10. NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin.
Panicucci R; Heal R; Laderoute K; Cowan D; McClelland RA; Rauth AM
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1039-43. PubMed ID: 2703383
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
Brown DM; Yu NY; Brown JM; Lee WW
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
Agrawal KC; Rupp WD; Rockwell S
Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
[TBL] [Abstract][Full Text] [Related]
13. NLNQ-1, a 2-[3-(2-nitro-1-imidazolyl) propylamino]-3-chloro-1,4-naphthoquinone, as a hypoxia-selective cytotoxin and radiosensitizer.
Papadopoulou MV; Bloomer WD
In Vivo; 2008; 22(3):285-8. PubMed ID: 18610737
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
Fitzpatrick DA; Heindel ND; Egolf RA; Walton H
Radiat Res; 1989 Jan; 117(1):47-58. PubMed ID: 2913608
[TBL] [Abstract][Full Text] [Related]
15. In vitro hypoxic cytotoxicity and hypoxic radiosensitization. Efficacy of the novel 2-nitroimidazole N,N,N-tris[2-(2-nitro-1H-imidazol-1-yl)ethyl]amine.
Langenbacher M; Abdel-Jalil RJ; Voelter W; Weinmann M; Huber SM
Strahlenther Onkol; 2013 Mar; 189(3):246-54. PubMed ID: 23361139
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic studies of enhanced in vitro radiosensitization and hypoxic cell cytotoxicity by targeting radiosensitizers to DNA via intercalation.
Cowan DS; Kanagasabapathy VM; McClelland RA; Rauth AM
Int J Radiat Oncol Biol Phys; 1992; 22(3):541-4. PubMed ID: 1735693
[TBL] [Abstract][Full Text] [Related]
17. Chloronitroimidazoles as radiosensitizers of hypoxic cells in vitro.
Wideł M; Watras J; Suwiński J; Salwińska E
Neoplasma; 1987; 34(3):241-51. PubMed ID: 3614460
[TBL] [Abstract][Full Text] [Related]
18. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
Cole S; Stratford IJ; Adams GE; Fielden EM; Jenkins TC
Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials of radiosensitizers: what should we expect?
Brown JM
Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitizing ability and cytotoxicity of some 5(4)-substituted 2-methyl-4(5)-nitroimidazoles.
Wideł M; Watras J; Suwiński J; Salwińska E
Neoplasma; 1982; 29(4):407-15. PubMed ID: 7133232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]